Safety and Efficacy of the SurVeil™ Drug-Coated Balloon

NACompletedINTERVENTIONAL
Enrollment

446

Participants

Timeline

Start Date

October 23, 2017

Primary Completion Date

September 15, 2020

Study Completion Date

September 17, 2024

Conditions
Peripheral Arterial DiseasePeripheral Vascular DiseaseArtery Disease, PeripheralFemoropopliteal Artery Occlusion
Interventions
DEVICE

Surmodics SurVeil DCB

Angioplasty procedure with a paclitaxel-coated, percutaneous transluminal angioplasty (PTA) balloon catheter.

DEVICE

Medtronic IN.PACT Admiral DCB

Angioplasty procedure with a paclitaxel-coated, percutaneous transluminal angioplasty (PTA) balloon catheter.

Trial Locations (63)

10032

Columbia University Medical Center/NYPH, New York

17011

Capital Area Research, Camp Hill

17043

Pinnacle Health Cardiovascular Institute, Wormleysburg

19141

Bryn Mawr Hospital - Main Line Health System (Einstein), Philadelphia

20010

MedStar Washington Hospital Center, Washington D.C.

27401

Moses Cone-LeBauer, Greensboro

27607

North Carolina Heart and Vascular, Raleigh

28801

Mission Hospital, Asheville

30309

Piedmont Heart Insitute, Atlanta

30322

Emory University Hospital (Clifton), Atlanta

30501

Northeast Georgia Medical Center, Gainesville

33756

Clearwater Cardiovascular Consultants, Clearwater

34478

Advent Health Ocala/MediQuest Research Group LLC (formerly FL Hospital /Munroe), Ocala

35243

Cardiovascular Associates of the Southeast, Birmingham

36535

Cardiology Associates, Foley

37660

Ballad Health System, Kingsport

37934

Turkey Creek Medical Center, Knoxville

39401

Hattiesburg Clinic, Hattiesburg

43214

Ohio Health Research Institute, Columbus

43614

University of Toledo Medical Center, Toledo

44035

North Ohio Heart Center, Elyria

44195

Cleveland Clinic, Cleveland

45219

The Lindner Clinical Trial Center, Cincinnati

46290

St Vincent Heart (Research Department), Indianapolis

49770

Northern Michigan Hospital, Petoskey

50266

Iowa Heart Center, West Des Moines

55422

North Memorial Hospital, Robbinsdale

60007

Alexian Brothers Medical Center, Elk Grove Village

60540

Advocate Health, Naperville

62701

Prairie Education (PERC), Springfield

65804

Mercy Hospital, Springfield

66160

University of Kansas Medical Center, Kansas City

68198

University of Nebraska, Omaha

70433

Cardiovascular Associates Research, Covington

71111

Endovascular Technologies, LLC, Bossier City

73120

Oklahoma Cardiovascular Research Group, Oklahoma City

75069

North Dallas Research Associates, McKinney

77030

Houston Cardiovascular Association, Houston

78756

St. David's Heart & Vascular PLLC dba Austin Heart, Austin

85297

Dignity Health, Gilbert

85364

Yuma Regional Medical Center, Yuma

94538

Mission Cardiovascular Research Institute, Fremont

97225

Providence Heart and Vascular, Portland

06510

Yale New Haven Hospital, New Haven

02135

St. Elizabeth's Medical Center, Boston

02215

Beth Israel Deaconess, Boston

08034

Virtua Medical Group, P.A., Cherry Hill

07102

St. Michael's Hospital, Newark

07666

Holy Name Medical Center, Teaneck

02906

The Miriam Hospital, Providence

Unknown

Prince of Wales Private Hostpital, Randwick

Institution Medizinische Universitat, Graz

AZ Sint Blasius, Dendermonde

UZ GENT, Ghent

FN u sv. Anny v Brně a LF MU (Centrum cévních onemocnění II. chirurgická klinika), Brno

Vitkovicka Nemocnice Ostrava Vítkovická nemocnice, a.s.,, Ostrava

Herz Zentrum Bad Krozingen Südring, Bad Krozingen

SRH Klinikum KarlsbadLangensteinbach, Karlsbad

Universitätsklinikum Leipzig, Leipzig

REGIOMED-KLINIKEN GmbH, Sonneberg

Aou Careggi University Hospital, Florence

Pauls Stradins Clinical University Hospital, Riga

Auckland City Hospital, Auckland

All Listed Sponsors
lead

SurModics, Inc.

INDUSTRY

NCT03241459 - Safety and Efficacy of the SurVeil™ Drug-Coated Balloon | Biotech Hunter | Biotech Hunter